References
- Hoofnagle J H, Peters M, Mullen K D, et al. Randomized, controlled trials of recombinant human alpha-interferon in patients with chronic hepatitis B. Gastroenterology 1988; 95: 1318–25
- Perrillo R P, Schiff E R, Davis G L, et al. A randomized trial of interferon alpha-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. New Engl J Med 1989; 323: 295–301
- Kassianides C, Di Bisceglie A, Hoofnagle J H, . Alpha-interferon therapy in patients with decompensated chronic type B hepatitis. Viral hepatitis and liver diseases, A J Zuckerman, et al. Alan R. Liss, New York 1988; 840–3
- Nevens J, Goubau P, Van Eyken P, Desmyter J, Desmet V, Fevery J. Treatment of decompensated viral hepatitis B-induced liver cirrhosis with low doses of interferon alpha. Liver 1993; 13: 15–9
- Marcellin P, Samuel D, Areias J, et al. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease. Hepatology 1994; 19: 6–12
- Samuel D, Muller R, Alexander G, et al. Liver transplantation in European patients with the hepatitis-B surface antigen. N Engl J Med 1993; 329: 1842–7
- Samuel D, Bismuth H. Liver transplantation for hepatitis B. Gastroenterology Clin North Am 1993; 22: 271–83
- O'Grady J G, Smith H M, Davies S E, et al. Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol 1992; 14: 104–11
- Degos F, Lugassy C, Degott C, et al. Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients: a prospective study of 90 patients. Gastroenterology 1988; 94: 151–6
- Nagington J, Cossart Y E, Cohen B J. Reactivation of hepatitis B after transplantation operations. Lancet 1977; 1: 558–60
- Tur-Kaspa R, Burk R D, Shaul Y, Shafritz D A. Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci USA 1986; 83: 1627–31
- McMahon G, McCarthy L A, Dottavio D, Ostberg L. Surface antigen and polymerase gene variation in hepatitis B virus isolates from a monoclonal antibody-treated liver transplant patient. Viral hepatitis and liver disease, F B Hollinger, S M Lemon, H S Margelis. Williams and Wilkins, Baltimore 1991; 219–21
- McMahon G, Ehrlich P H, Moustafa Z A, et al. Genetic alterations in the gene encoding the major HBsAg:DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology 1992; 15: 757–66
- Fang J WS, Tung F YT, Davis G L, Dolson D J, Van Thiel D H, Lau J YN. Fibrosing cholestatic hepatitis in a transplant recipient with hepatitis B virus precore mutant. Gastroenterology 1993; 105: 901–4
- Harrison R F, Davies M H, Goldin R D, Hubscher S G. Recurrent hepatitis-B in liver allografts—a distinctive form of rapidly developing cirrhosis. Histopathology 1993; 23: 21–8
- Walker N, Apel R, Kerlin P, et al. Hepatitis B virus infection in liver allografts. Am J Surg Pathol 1993; 17: 666–77
- Benner K G, Lee R G, Keeffe E B, Lopez R R, Sasaki A W, Pinson C W. Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology 1992; 103: 1307–12
- Mason A L, Wick M, White H M, et al. Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis. Gastroenterology 1993; 105: 237–44
- Lau Y, Bain V G, Davies S E, et al. High-level expression of hepatitis B-viral II antigens in fibrosing cholestatic hepatitis. Gastroenterology 1992; 102: 956–62
- Müller R, Gubernatis G, Farle M, et al. Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 1991; 13: 90–6
- Todo S, Demetris A J, van Thiel D, Teperman L, Fung J J, Starzl T E. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991; 13: 619–26